<DOC>
	<DOCNO>NCT02729597</DOCNO>
	<brief_summary>The natural history brain affection myotonic dystrophy type 1 2 still unknown . The investigator design 5-year longitudinal neuropsychological neuroimaging follow-up study address issue . Myotonic dystrophy type 1 , myotonic dystrophy type 2 patient , healthy control enrol . All participant undergo clinical-neurological examination , neuropsychological analysis accord 13-item neuropsychological test battery , 3T-brain MRI include voxel-based morphometry diffusion tensor image baseline follow-up use identical examination protocol .</brief_summary>
	<brief_title>Tracking Brain Myotonic Dystrophies : 5-year Longitudinal Follow-up Study</brief_title>
	<detailed_description>It unknown whether brain affection myotonic dystrophy type 1 2 due neurodevelopmental defect , neurodegeneration , . An exact definition nature dynamic brain affection urgent need identification clinical trial outcome parameter design therapy compound . The investigator plan 5-year longitudinal study examine natural history functional structural brain affection . Myotonic dystrophy type 1 , myotonic dystrophy type 2 patient , healthy control enrol . All participant undergo clinical-neurological examination , neuropsychological analysis accord 13-item neuropsychological test battery , 3T-brain MRI baseline follow-up use identical examination protocol . The intended time span baseline follow-up examination 5 year minimum . To investigate gray white matter affection , voxel-based morphometry diffusion tensor imaging perform , data statistically analyze include ( ) group comparison patient control baseline follow-up , ( ii ) group comparison use difference map focus isolate disease-related effect time .</detailed_description>
	<mesh_term>Myotonic Dystrophy</mesh_term>
	<criteria>Inclusion criterion healthy control : write informed consent normal neurological examination without acute former neurological severe psychiatric disease , medical history traumatic brain injury Inclusion criterion patient : write informed consent diagnosis confirm genetic test neurological severe psychiatric disease , medical history traumatic brain injury Exclusion criterion healthy control patient : use psychoactive substance include alcohol ( except nicotine ) , formerly currently ; treatment modafinil severe psychiatric disorder , serious physical illness , particularly cardiovascular disease , formerly currently nonremovable ferromagnetic metallic implant , sensor , stimulators , prosthesis , pacemaker , large tattoo claustrophobia age 18 year</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>neuromuscular disorder</keyword>
	<keyword>MRI</keyword>
	<keyword>white matter</keyword>
	<keyword>brain</keyword>
	<keyword>myotonic dystrophy</keyword>
</DOC>